India’s pharmaceutical industry stands at the crossroads of a period rich with opportunity and uncertainty as businesses are confronted by the need to generate growth in a mature, competitive market while faced with increasing pricing pressures, evolving government regulations and protectionist policies.
As the world’s third-largest pharmaceutical industry by volume, this sector has borne witness to a remarkable influx of private investment, particularly within the API (Active Pharmaceutical Ingredients) segment and the broader domain. With clear interest in revenue growth, trends toward deregulation and government incentives and policies (PLI, SPI, Bulk Drug Parks and PTUA Schemes), India is clearly looking at this sector as a core driver of growth.
ELP’s pharmaceutical offering includes a multi-disciplinary team of experts from its corporate, regulatory, international trade, tax, anti-trust, white collar crimes and disputes teams. Working with both domestic and multinational companies, we have a deep understanding of the legal and regulatory landscape governing the pharmaceutical industry in India, as well as the unique business and ethical considerations that come with this sector.
Our services include:
Alerts & Updates 17th Jul 2024
Pharmaceutical Regulations: A move towards greater transparency and accountability
READ MOREAlerts & Updates 29th Nov 2023
Delhi High Court Judgment in Bharat Serums – a relief to Drug Manufacturers
READ MORENews & Media 27th Nov 2023
Proposed NPC Bill to promote innovation & research in pharmacy: Experts
READ MOREArticles 18th Aug 2023
Quality controls standards and the EV charging ecosystem: All you need to know
READ MORENewsletter/Booklets 7th Jul 2023
Market Access Barriers in The Pharmaceutical Sector in India’s Key Export Destinations
READ MOREAlerts & Updates 6th Jul 2023
Whale Of A Tale: Tracing The Centre’s Recent Ban On 14 FDCs Approved Prior To 1988
READ MOREAlerts & Updates 8th Jun 2023
Regulatory Blindspot and Contradictions: Sale, Manufacturing and Price Regulation of India’s Medical Devices market
READ MOREAssisted Piramal Enterprises in acquisition of 100% of shares in Hemmo Pharmaceuticals Private Limited by way of share transfer from...
READ MORE +
Advised Somerset Indus Healthcare Fund on acquisition of a minority stake in Hexagon Nutrition Private Limited, a nutrition products company.
Regularly rendering comprehensive indirect tax advisory and litigation services on a gamut of key issues and transactions for Johnson &...
READ MORE +
Assisting and representing various Indian conglomerates and trade associations, across sectors, including pharmaceuticals, automotive and FMCG before the RoDTEP Committee.
Advising and representing a Group of pharmaceutical companies in relation to actions initiated by a cancer drug manufacturer, challenging the...
READ MORE +
Advised one of the world’s Leading pharmaceutical manufacturers in an investigation pending before the CCI on allegations of price fixing...
READ MORE +
As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.